PT - JOURNAL ARTICLE AU - Pyne, Elise AU - Joyce, Robert AU - Dwyer, Christopher P. AU - Hynes, Sinéad M. TI - Evaluating public and patient involvement in interventional research – a newly developed checklist (EPPIIC) with application to the COB-MS feasibility trial AID - 10.1101/2024.03.17.24304433 DP - 2024 Jan 01 TA - medRxiv PG - 2024.03.17.24304433 4099 - http://medrxiv.org/content/early/2024/03/18/2024.03.17.24304433.short 4100 - http://medrxiv.org/content/early/2024/03/18/2024.03.17.24304433.full AB - Public and patient involvement (PPI) has been identified as an increasingly desired and, often, required component of trial methodology – leading to higher quality, more accessible and relevant clinical research, alongside increased recruitment, funding success and insight into research impact. However, despite the great variety of frameworks and checklists available for assessing PPI, most are limited with respect to important features (e.g. applicable in specific contexts only, fail to clarify what should be assessed and reported, lack the necessary comprehensiveness or are biased in favour of researcher reporting). Thus, the current research aimed to address such limitations through the development of a new checklist, the EPPIIC, through review, thematic analysis and ‘meta-evaluation’ in conjunction with PPI engagement. A further aim was to pilot the EPPIIC through its application to and reporting on the COB-MS trial, which utilised PPI throughout the research’s life-cycle. Upon completion of the EPPIIC, three thematic ‘sub-scales’ emerged: (1) Policy & Practice, (2) Participatory Culture and (3) Influence & Impact. All findings are presented and discussed in light of theory and research. Notably, findings recommend EPPIIC as a useful means of assessing PPI in future trials.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNA- this research is not reporting on a clinical trial. It is, however, evaluating PPI in a clinical trial - ISRCTN: ISRCTN11462710. Registered on 9 September 2019 and updated on 23 September 2020.Clinical Protocols https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-023-07080-y Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval is not required for this research. The COB-MS trial that is evaluated in this manuscript has full ethical approval - Ethical approval was awarded by Galway University Hospitals on 13.08.2019 Ref C. A 223.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files.